GlassScriptPhysician profile
Jose A Caceres
NPI 1992766604
$12,471.70
in general payments reported to CMS, 2019-2025
51 companies · $1,566 in 2025
The $1,566 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,572 · 2020: $1,223 · 2021: $2,254 · 2022: $1,863 · 2023: $1,969 · 2024: $2,024 · 2025: $1,566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,559.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,559.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,337.79 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,304.26 | 2019-2025 | Farxiga, Breztri, Brilinta |
| Amgen INC. | $1,087.66 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $773.81 | 2019-2025 | Lifevest |
| Pfizer INC. | $765.79 | 2019-2025 | |
| Novo Nordisk INC | $732.02 | 2020-2025 | Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $681.21 | 2019-2025 | Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $668.79 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $594.70 | 2020-2024 | Xarelto, Spravato |
| Kowa Pharmaceuticals America, INC. | $532.65 | 2019-2023 | Seglentis, Livalo |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $474.26 | 2019-2025 | Xifaxan, Trulance |
| Merck Sharp & Dohme LLC | $374.60 | 2021-2025 | Verquvo, Gardasil 9, Capvaxive |
| Biotronik INC. | $233.06 | 2019-2021 | |
| Abbott Laboratories | $222.20 | 2019-2023 | Mitraclip |
| Phathom Pharmaceuticals, INC. | $213.98 | 2024-2025 | Voquezna |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $203.23 | 2021-2025 | |
| Astellas Pharma US INC | $200.66 | 2019-2025 | Veozah |
| Cardinal Health 200 LLC | $159.22 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $154.70 | 2019 | |
| Scpharmaceuticals INC. | $152.20 | 2024-2025 | |
| Zynex Medical, INC. | $147.16 | 2025 | Nexwave |
| Abbvie INC. | $115.92 | 2021-2022 | |
| Lilly USA, LLC | $114.76 | 2021-2024 | Zepbound |
| Dexcom, INC. | $114.66 | 2023-2025 | Dexcom G6 Transmitter |
| Cardiovascular Systems INC. | $96.98 | 2019-2023 | Diamondback Coronary |
| Esperion Therapeutics, INC. | $95.23 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $81.89 | 2019-2025 | Eliquis |
| Regeneron Healthcare Solutions, INC. | $79.13 | 2019 | |
| Stryker Corporation | $78.76 | 2025 | Clottriever Bold Catheter, Flowtriever |
| Amarin Pharma, INC. | $77.65 | 2020-2021 | |
| Actelion Pharmaceuticals US, INC. | $55.99 | 2024-2025 | Opsumit, Uptravi |
| Edwards Lifesciences Corporation | $55.60 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Xeris Pharmaceuticals, INC. | $46.50 | 2023 | Gvoke Hypopen |
| Amicus Therapeutics, INC. | $36.61 | 2020-2021 | |
| Boston Scientific Corporation | $33.89 | 2025 | Avvigo Guidance System |
| Axsome Therapeutics, INC. | $32.86 | 2023 | Auvelity |
| Abiomed | $31.60 | 2021 | |
| Verona Pharma, INC. | $29.69 | 2025 | Ohtuvayre |
| Sumitomo Pharma America, INC. | $29.34 | 2024 | Gemtesa |
| Terumo Medical Corporation | $28.79 | 2022 | |
| Grifols USA, LLC | $24.56 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $23.40 | 2023 | Inpefa |
| Biohaven Pharmaceutical Holding Company LTD. | $23.00 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $22.85 | 2019-2021 | |
| Genzyme Corporation | $21.18 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $20.42 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $20.01 | 2021 | |
| Baxter Healthcare | $19.30 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Philips North America LLC | $17.95 | 2021 | |
| Teleflex LLC | $14.93 | 2019 | |
| Gilead Sciences, INC. | $14.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Caceres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.